Moderna, Inc.
(NASDAQ : MRNA)

( )
MRNA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. 0.94%245.371.5%$928.59m
MRNAModerna, Inc. 0.71%144.270.0%$827.22m
REGNRegeneron Pharmaceuticals, Inc. 0.84%612.492.6%$518.34m
GILDGilead Sciences, Inc. 0.80%63.081.0%$507.58m
VRTXVertex Pharmaceuticals, Inc. 3.19%292.551.9%$481.51m
NVAXNovavax, Inc. -0.27%51.6775.7%$417.87m
ILMNIllumina, Inc. 0.20%193.933.3%$327.84m
BIIBBiogen, Inc. 0.26%211.931.8%$220.55m
SNSSSunesis Pharmaceuticals, Inc. 9.63%2.960.7%$206.91m
CRSPCRISPR Therapeutics AG 2.78%66.960.6%$167.22m
BNTXBioNTech SE 1.32%134.040.0%$150.84m
BMRNBioMarin Pharmaceutical, Inc. 2.72%86.854.2%$114.78m
EXASEXACT Sciences Corp. 6.89%45.1517.7%$99.68m
TECHBio-Techne Corp. 2.16%352.764.5%$94.64m
IOVAIovance Biotherapeutics, Inc. 0.19%10.350.0%$93.26m

Company Profile

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.